Antibody Discovery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Monoclonal Antibodies, Polyclonal Antibodies, Other Antibody Types); End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, Others) and Geography
Report Code: TIPRE00007411 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET OVERVIEW
The process of discovering new therapeutic antibodies to fight diseases like as HIV, cancers, hereditary disorders and others is known as antibody-drug discovery and development. The technology used to discover these antibodies, or therapeutic candidates, has transformed how industries and labs conduct science. Monoclonal antibodies have emerged as a critical therapeutic for cancer, inflammation, and a variety of other disorders. Increase in R&D expenditures by pharmaceutical and biopharmaceutical companies to develop therapeutic antibodies along with rising demand for antibodies in immunotherapy are expected to boost market growth during the forecast period.
MARKET SCOPE
The Global Antibody Discovery Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibody discovery market with detailed market segmentation by type and end user. The report provides key statistics on the market status of the leading antibody discovery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibody discovery market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antibody discovery market in these regions.
IMPACT OF COVID-19 ON ANTIBODY DISCOVERY MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the antibody discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antibody discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for Antibody discovery in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antibody discovery market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The process of discovering new therapeutic antibodies to fight diseases like as HIV, cancers, hereditary disorders and others is known as antibody-drug discovery and development. The technology used to discover these antibodies, or therapeutic candidates, has transformed how industries and labs conduct science. Monoclonal antibodies have emerged as a critical therapeutic for cancer, inflammation, and a variety of other disorders. Increase in R&D expenditures by pharmaceutical and biopharmaceutical companies to develop therapeutic antibodies along with rising demand for antibodies in immunotherapy are expected to boost market growth during the forecast period.
MARKET SCOPE
The Global Antibody Discovery Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibody discovery market with detailed market segmentation by type and end user. The report provides key statistics on the market status of the leading antibody discovery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type the market is segmented as, monoclonal antibodies, polyclonal antibodies and other antibody types.
- Based on end user the market is segmented as, pharmaceutical and biotechnology companies, research laboratories and other.
MARKET DYNAMICS
Drivers:
- Increase in R&D expenditures by pharmaceutical and biopharmaceutical companies to develop therapeutic antibodies.
- Rising demand for antibodies in immunotherapy for metastatic diseases, cancers is expected to create significant growth opportunities for the market.
- Increasing industry and academic collaboration is also expected to spur the market growth.
Restraints:
- However, high cost associated with research and development activities are expected to restrain market growth during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibody discovery market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antibody discovery market in these regions.
IMPACT OF COVID-19 ON ANTIBODY DISCOVERY MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the antibody discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antibody discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for Antibody discovery in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antibody discovery market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Alcami Corporation, Inc.
- BASF SE
- Bioduro-Sundia
- Bruker
- Cambrex Corporation
- Croda International Plc
- Aragen Life Sciences Pvt. Ltd
- Eurofins DiscoverX Corporation
- NanoCellect Biomedical
- Sartorius AG
The List of Companies
1. Alcami Corporation, Inc.
2. BASF SE
3. Bioduro-Sundia
4. Bruker
5. Cambrex Corporation
6. Croda International Plc
7. Aragen Life Sciences Pvt. Ltd
8. Eurofins DiscoverX Corporation
9. NanoCellect Biomedical
10. Sartorius AG
11. Integral Molecular, Inc
12. Cambridge Research Biochemicals Limited
13. ImmunoPrecise Antibodies Ltd
1. Alcami Corporation, Inc.
2. BASF SE
3. Bioduro-Sundia
4. Bruker
5. Cambrex Corporation
6. Croda International Plc
7. Aragen Life Sciences Pvt. Ltd
8. Eurofins DiscoverX Corporation
9. NanoCellect Biomedical
10. Sartorius AG
11. Integral Molecular, Inc
12. Cambridge Research Biochemicals Limited
13. ImmunoPrecise Antibodies Ltd
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount